Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering-Plough

This article was originally published in The Tan Sheet

Executive Summary

Sun care sales leaped 28% to $92 mil. in second quarter on initial sell-in of Coppertone Endless Summer sunless tanning lotion, firm tells analysts June 25. Foot care revenues fell 3% to $97 mil. "due to increased competition"; OTC sales dropped 5% to $42 mil. Company previously predicted OTC business shortfall due to GMP problems (1"The Tan Sheet" Feb. 19, p. 7). CEO Richard Kogan says Schering has "made progress toward resolving these manufacturing issues." Net sales and income both were flat at $2.63 bil. and $634 mil., respectively

You may also be interested in...



Schering-Plough Reduced OTC Sales Forecast Due To GMP Problems

Certain OTC products manufactured by Schering-Plough will see reduced sales due to a problematic manufacturing process and control issues cited by FDA, the company said.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel